153 related articles for article (PubMed ID: 30410940)
1. Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells.
Foong JN; Selvarajah GT; Rasedee A; Rahman HS; How CW; Beh CY; Teo GY; Ku CL
Biomed Res Int; 2018; 2018():8691569. PubMed ID: 30410940
[TBL] [Abstract][Full Text] [Related]
2. Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model.
Rahman HS; Rasedee A; How CW; Zeenathul NA; Chartrand MS; Yeap SK; Abdul AB; Tan SW; Othman HH; Ajdari Z; Namvar F; Arulselvan P; Fakurazi S; Mehrbod P; Daneshvar N; Begum H
Int J Nanomedicine; 2015; 10():1649-66. PubMed ID: 25767386
[TBL] [Abstract][Full Text] [Related]
3. Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line.
Rahman HS; Rasedee A; Abdul AB; Zeenathul NA; Othman HH; Yeap SK; How CW; Hafiza WA
Int J Nanomedicine; 2014; 9():527-38. PubMed ID: 24549090
[TBL] [Abstract][Full Text] [Related]
4. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect.
Rahman HS; Rasedee A; How CW; Abdul AB; Zeenathul NA; Othman HH; Saeed MI; Yeap SK
Int J Nanomedicine; 2013; 8():2769-81. PubMed ID: 23946649
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone loaded in nanostructured lipid carrier showed enhanced anticancer activity in 4T1 tumor-bearing mice.
Ong YS; Saiful Yazan L; Ng WK; Abdullah R; Mustapha NM; Sapuan S; Foo JB; Tor YS; How CW; Abd Rahman N; Zakarial Ansar FH
Nanomedicine (Lond); 2018 Jul; 13(13):1567-1582. PubMed ID: 30028248
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of 4-dedimethylamino sancycline (CMT-3) loaded nanostructured lipid carrier (CMT-3/NLC) formulations.
Yang X; Zhao L; Almasy L; Garamus VM; Zou A; Willumeit R; Fan S
Int J Pharm; 2013 Jun; 450(1-2):225-34. PubMed ID: 23608200
[TBL] [Abstract][Full Text] [Related]
7. Acute toxicity study of zerumbone-loaded nanostructured lipid carrier on BALB/c mice model.
Rahman HS; Rasedee A; Othman HH; Chartrand MS; Namvar F; Yeap SK; Abdul Samad N; Andas RJ; Muhammad Nadzri N; Anasamy T; Ng KB; How CW
Biomed Res Int; 2014; 2014():563930. PubMed ID: 25276798
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway.
Wang F; Ye X; Zhai D; Dai W; Wu Y; Chen J; Chen W
Acta Pharm; 2020 Jun; 70(2):227-237. PubMed ID: 31955141
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic effect of Zerumbone on melanoma cells through mitochondria-mediated pathways.
Wang SD; Wang ZH; Yan HQ; Ren MY; Gao SQ; Zhang GQ
Clin Exp Dermatol; 2016 Dec; 41(8):858-863. PubMed ID: 27759171
[TBL] [Abstract][Full Text] [Related]
10. Zerumbone, a Sesquiterpene, Controls Proliferation and Induces Cell Cycle Arrest in Human Laryngeal Carcinoma Cell Line Hep-2.
Jegannathan SD; Arul S; Dayalan H
Nutr Cancer; 2016 Jul; 68(5):865-72. PubMed ID: 27045964
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
Chen Y; Pan L; Jiang M; Li D; Jin L
Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
13. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway.
Xian M; Ito K; Nakazato T; Shimizu T; Chen CK; Yamato K; Murakami A; Ohigashi H; Ikeda Y; Kizaki M
Cancer Sci; 2007 Jan; 98(1):118-26. PubMed ID: 17129359
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Abu N; Mohamad NE; How CW; Masarudin MJ; Abdullah R; Alitheen NB
Sci Rep; 2019 Feb; 9(1):1614. PubMed ID: 30733560
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol: Isolation, and Its Nanostructured Lipid Carriers, Inhibits Cell Proliferation, Induces Cell Apoptosis in Certain Human Cell Lines Carcinoma and Exerts Protective Effect Against Paraquat-Induced Hepatotoxicity.
Elgizawy HA; Ali AA; Hussein MA
J Med Food; 2021 Jan; 24(1):89-100. PubMed ID: 32580673
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.
Wang F; Chen J; Dai W; He Z; Zhai D; Chen W
Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837
[TBL] [Abstract][Full Text] [Related]
19. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
[TBL] [Abstract][Full Text] [Related]
20. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells.
Abdelwahab SI; Abdul AB; Mohan S; Taha MM; Syam S; Ibrahim MY; Mariod AA
Leuk Res; 2011 Feb; 35(2):268-71. PubMed ID: 20708800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
